奈帕芬胺
此條目可參照英語維基百科相應條目來擴充。 (2024年8月11日) |
臨床資料 | |
---|---|
商品名 | Nevanac, Ilevro, Amnac, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a606007 |
核准狀況 | |
懷孕分級 | |
給藥途徑 | Topical eye drops |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
識別資訊 | |
| |
CAS號 | 78281-72-8 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.207.414 |
化學資訊 | |
化學式 | C15H14N2O2 |
摩爾質量 | 254.29 g·mol−1 |
3D模型(JSmol) | |
| |
|
奈帕芬胺(英語:Nepafenac,商品名:Nevanac、Ilevro等)是一種含氮有機化合物,分子式C15H14N2O2,屬於非甾體抗炎藥(NSAID),可作為眼藥水處方藥[3],其在體內的活性代謝產物為氨芬酸[4][5]。
參考文獻
- ^ Nepafenac ophthalmic Use During Pregnancy. Drugs.com. 6 June 2019 [13 September 2020].
- ^ Prescription medicines: registration of new chemical entities in Australia, 2015. Therapeutic Goods Administration (TGA). 21 June 2022 [10 April 2023].
- ^ Nepafenac Monograph
- ^ Drugbank: Nepafenac
- ^ Zanetti FR, Fulco EA, Chaves FR, da Costa Pinto AP, Arieta CE, Lira RP. Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology. July 2012, 60 (4): 277–81. PMC 3442462 . PMID 22824596. doi:10.4103/0301-4738.98705 .
外部連結
- Nepafenac. Drug Information Portal. U.S. National Library of Medicine.